MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma.
Oncoimmunology
; 11(1): 2035919, 2022.
Article
in En
| MEDLINE
| ID: mdl-35223192
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bile Duct Neoplasms
/
Cholangiocarcinoma
Limits:
Humans
Language:
En
Journal:
Oncoimmunology
Year:
2022
Type:
Article
Affiliation country:
Italy